Almost two decades later in 1974, pivotal studies by Smith and Hall showed that these autoantibodies in sera of patients with Graves’ disease target the TSH receptor (TSHR) and stimulation of the TSHR by autoantibodies is responsible for thyroid overactivity in Graves’ disease [2]. Here, TSHR is linked to Graves disease.